04 Mar

Nasal Vaccine Could Replace Seasonal Shots

A new vaccine developed by Stanford medicine could provide protection from respiratory viruses, bacteria, allergens – even the common cold.  In a study in mice, the “nearly universal” vaccine (GLA-3M-052-LS+OVA), which is delivered intranasally (e.g., through a nasal spray), provided at least 3...
18 Feb

FDA Reverses Refusal-to-File on mRNA Flu Vaccine

After notifying Moderna last week that its application for review of its mRNA-1010 flu vaccine would not be reviewed for possible approval, the FDA reversed its decision based on additional discussion with and revised regulatory approach proposal from Moderna. An...

Ready to elevate your brand protection?